Fritz Lang
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 5
- Pancreatic and Hepatic Oncology Research 3
- Neutropenia and Cancer Infections 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Gabriela Verena Kornek (14 shared papers)Werner Scheithauer (15 shared papers)Dieter Depisch (14 shared papers)Markus Raderer (8 shared papers)Bruno Schneeweiß (6 shared papers)Birgit Schüll (6 shared papers)Erwin Kovats (6 shared papers)Katharina Emanuela Schmid (3 shared papers)
In The Last Decade
Fritz Lang
15 papers receiving 636 citations
Peers
Comparison fields: 5 of 50
- Oncology 440
- Hepatology 46
- Pulmonary and Respiratory Medicine 154
- Cancer Research 67
- Surgery 165
Countries citing papers authored by Fritz Lang
This map shows the geographic impact of Fritz Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz Lang more than expected).
Fields of papers citing papers by Fritz Lang
This network shows the impact of papers produced by Fritz Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz Lang. The network helps show where Fritz Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fritz Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 149 | |
| 2 | 2004 | 119 | |
| 3 | 2003 | 102 | |
| 4 | 2005 | 49 | |
| 5 | 1999 | 41 | |
| 6 | Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor. | 2002 | 40 |
| 7 | 2001 | 36 | |
| 8 | 2002 | 35 | |
| 9 | 2002 | 24 | |
| 10 | 2002 | 21 | |
| 11 | 2003 | 18 | |
| 12 | 2007 | 14 | |
| 13 | 2006 | 10 | |
| 14 | 2009 | 8 | |
| 15 | 1999 | 2 |
About Fritz Lang
Fritz Lang is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Epidemiology and Hematology, having authored 15 papers that have together received 668 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Gastric Cancer Management and Outcomes (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Neutropenia and Cancer Infections (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Oncology (440 citations), Hepatology (46 citations), Pulmonary and Respiratory Medicine (154 citations), Cancer Research (67 citations) and Surgery (165 citations). Fritz Lang has collaborated with scholars based in Austria, Germany and India. Frequent co-authors include Gabriela Verena Kornek, Werner Scheithauer, Dieter Depisch, Markus Raderer, Bruno Schneeweiß, Birgit Schüll, Erwin Kovats, Katharina Emanuela Schmid, Alfred Lenauer and T. Gruenberger. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Oncology, Annals of Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.